Longaeva Partners’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Longaeva Partners's OBX Position: Q3 2026 in Review
Longaeva Partners opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 499,963 shares worth $6.63M. The stake represents 0.14% of the portfolio and ranks #161 among its holdings.
60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Longaeva Partners held 499,963 shares of Obsidian Therapeutics worth $6.63M as of Q3 2026.
- Obsidian Therapeutics was a new Longaeva Partners position in Q3 2026.
- Obsidian Therapeutics made up 0.14% of Longaeva Partners's portfolio in Q3 2026, its #161 holding.
- 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.